SecurityGSK / GlaxoSmithKline plc
InstitutionWellesley Investment Partners, LLC
Shares17,548
Value $ 707,000
Related 377372AG2 / Glaxosmithkline Cap Inc. 0.70% 03/18/16
377372AH0 / Glaxosmithkline Cap Inc. 2.80% 03/18/23
377372AJ6 / Glaxosmithkline Cap Inc. 4.20% 03/18/43
377372AA5 / Glaxosmithkline Cap Inc Guaranteed Notes 4.375% 04/15/14
377372AB3 / Glaxosmithkline Cap Inc Guaranteed Notes 5.375% 04/15/34
377373AC9 / Glaxosmithkline Capital 1.50% 05/08/17
377373AD7 / Glaxosmithkline Capital 2.85% 05/08/22
377372AC1 / Glaxosmithkline Capital 4.85% Guaranteed Notes 5/15/13
377372AD9 / Glaxosmithkline Capital 5.65% Guaranteed Notes 5/15/18
377372AE7 / Glaxosmithkline Capital 6.375% Guaranteed Notes 5/15/38
377373AB1 / Glaxosmithkline Capital .75% 05/08/15

Wellesley Investment Partners, LLC reports 0.74% decrease in ownership of GSK / GlaxoSmithKline plc

August 14, 2018 - Wellesley Investment Partners, LLC has filed a 13F-HR form disclosing ownership of 17,548 shares of GlaxoSmithKline plc (NYSE:GSK) with total holdings valued at $707,000 USD as of June 30, 2018. Wellesley Investment Partners, LLC had filed a previous 13F-HR on May 14, 2018 disclosing 17,678 shares of GlaxoSmithKline plc at a value of $690,000 USD. This represents a change in shares of -0.74 percent and a change in value of 2.46 percent during the quarter.

Other investors with positions similar to Wellesley Investment Partners, LLC include Kcs Wealth Advisory, Fiduciary Trust Co, Ballentine Partners, LLC, Old National Bancorp /in/, Ramsay, Stattman, Vela & Price, Inc., and MAVEN SECURITIES Ltd.

13F Filings

The Security, Class, and CUSIP columns in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names and cusips.

In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Effective
Date
Form Security Class CUSIP Share
Price
Shares Change
(%)
Value
(x1000)
Change
(%)
Cost
(x1000)
Profit
(x1000)
Return
(%)
2018-06-30 13F-HR N SPONSORED ADR 37733W105 39.66 17,548 -0.74 707 2.46 -5 22 3.21
2018-03-31 13F-HR N SPONSORED ADR 37733W105 37.25 17,678 8.08 690 18.97 49 61 10.48
2017-12-31 13F-HR N SPONSORED ADR 37733W105 38.00 16,356 16.13 580 1.58 86 -77 -13.54
2017-09-30 13F-HR N SPONSORED ADR 37733W105 41.80 14,084 2.26 571 -3.71 13 -35 -5.90
2017-06-30 13F-HR N SPONSORED ADR 37733W105 42.58 13,773 6.43 593 8.81 35 13 2.31
2017-03-31 13F-HR N SPONSORED ADR 37733W105 40.27 12,941 23.10 545 34.90 98 43 10.70
2016-12-31 13F-HR Glaxosmithkline SPONSORED ADR 37733W105 40.76 10,513 -12.36 404 -21.86 -60 -53 -10.17
2016-09-30 13F-HR Glaxosmithkline SPONSORED ADR 37733W105 43.19 11,995 -2.07 517 -2.45 -11 -2 -0.39
2016-06-30 13F-HR Glaxosmithkline SPONSORED ADR 37733W105 41.93 12,248 7.37 530 14.47 35 32 6.85
2016-03-31 13F-HR Glaxosmithkline SPONSORED ADR 37733W105 40.42 11,407 21.49 463 22.49 82 3 0.91
2015-12-31 13F-HR Glaxosmithkline SPONSORED ADR 37733W105 9,389 378


CUSIP: 37733W105